D.A. Davidson & Co’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.51M Buy
40,723
+11,203
+38% +$982K 0.02% 547
2026
Q1
$2.67M Buy
29,520
+18,597
+170% +$1.71M 0.02% 595
2025
Q4
$982K Sell
10,923
-1,202
-10% -$114K 0.01% 900
2025
Q3
$1.19M Sell
12,125
-100
-0.8% -$9.91K 0.01% 798
2025
Q2
$1.12M Sell
12,225
-285
-2% -$27.6K 0.01% 777
2025
Q1
$1.42M Buy
12,510
+603
+5% +$64.5K 0.01% 673
2024
Q4
$1.26M Buy
11,907
+3,175
+36% +$341K 0.01% 693
2024
Q3
$943K Sell
8,732
-2,574
-23% -$281K 0.01% 779
2024
Q2
$1.23M Buy
11,306
+460
+4% +$54.2K 0.01% 669
2024
Q1
$1.43M Sell
10,846
-1,619
-13% -$202K 0.01% 620
2023
Q4
$1.52M Buy
12,465
+1,984
+19% +$221K 0.01% 585
2023
Q3
$1.18M Buy
10,481
+294
+3% +$37.3K 0.01% 626
2023
Q2
$1.48M Sell
10,187
-73
-0.7% -$9.92K 0.02% 573
2023
Q1
$1.33M Buy
10,260
+170
+2% +$21.3K 0.01% 575
2022
Q4
$1.29M Sell
10,090
-1,069
-10% -$124K 0.02% 554
2022
Q3
$1.17M Buy
11,159
+26
+0.2% +$2.85K 0.02% 545
2022
Q2
$1.17M Sell
11,133
-774
-7% -$91.8K 0.01% 550
2022
Q1
$1.52M Buy
11,907
+10
+0.1% +$1.21K 0.02% 523
2021
Q4
$1.47M Sell
11,897
-79
-0.7% -$10.3K 0.02% 544
2021
Q3
$1.7M Buy
11,976
+49
+0.4% +$7.21K 0.02% 472
2021
Q2
$1.86M Buy
11,927
+173
+1% +$28K 0.02% 447
2021
Q1
$1.83M Buy
11,754
+949
+9% +$147K 0.02% 419
2020
Q4
$1.62M Buy
10,805
+48
+0.4% +$6.78K 0.02% 386
2020
Q3
$1.42M Sell
10,757
-878
-8% -$115K 0.02% 375
2020
Q2
$1.35M Sell
11,635
-1,688
-13% -$195K 0.03% 380
2020
Q1
$1.31M Sell
13,323
-215
-2% -$28.2K 0.03% 399
2019
Q4
$1.97M Sell
13,538
-1,946
-13% -$269K 0.03% 368
2019
Q3
$2.06M Sell
15,484
-249
-2% -$32.2K 0.04% 337
2019
Q2
$1.8M Sell
15,733
-173
-1% -$20.3K 0.03% 354
2019
Q1
$1.78M Buy
15,906
+1,901
+14% +$216K 0.03% 387
2018
Q4
$1.41M Buy
14,005
+476
+4% +$53.5K 0.03% 405
2018
Q3
$1.73M Sell
13,529
-5,104
-27% -$607K 0.03% 389
2018
Q2
$2.02M Buy
18,633
+793
+4% +$86.3K 0.04% 346
2018
Q1
$1.89M Sell
17,840
-31
-0.2% -$3.6K 0.04% 342
2017
Q4
$2.09M Buy
17,871
+888
+5% +$100K 0.04% 311
2017
Q3
$1.93M Buy
16,983
+172
+1% +$19.9K 0.04% 358
2017
Q2
$2.1M Buy
16,811
+145
+0.9% +$17.2K 0.05% 309
2017
Q1
$1.98M Buy
16,666
+900
+6% +$102K 0.05% 303
2016
Q4
$1.58M Buy
15,766
+280
+2% +$30K 0.04% 379
2016
Q3
$1.95M Buy
15,486
+4,511
+41% +$557K 0.05% 335
2016
Q2
$1.28M Buy
10,975
+912
+9% +$103K 0.04% 354
2016
Q1
$1.04M Sell
10,063
-62
-0.6% -$6K 0.03% 386
2015
Q4
$1.01M Buy
10,125
+5,068
+100% +$496K 0.03% 396
2015
Q3
$460K Buy
5,057
+110
+2% +$11K 0.02% 556
2015
Q2
$523K Sell
4,947
-536
-10% -$59.3K 0.02% 561
2015
Q1
$623K Sell
5,483
-670
-11% -$76.4K 0.02% 523
2014
Q4
$676K Sell
6,153
-240
-4% -$25.3K 0.02% 499
2014
Q3
$622K Sell
6,393
-426
-6% -$41.9K 0.02% 530
2014
Q2
$686K Buy
6,819
+30
+0.4% +$2.93K 0.02% 518
2014
Q1
$623K Sell
6,789
-3,346
-33% -$308K 0.02% 535
2013
Q4
$916K Buy
10,135
+4,849
+92% +$420K 0.03% 427
2013
Q3
$421K Sell
5,286
-148
-3% -$11.7K 0.02% 538
2013
Q2
$392K Buy
+5,434
New +$406K 0.02% 530

Other funds holding ZBH

D.A. Davidson & Co's ZBH Position: Q2 2026 in Review

D.A. Davidson & Co increased its Zimmer Biomet (ZBH) stake by 38% in Q2 2026, buying an estimated $982K and bringing the position to 40,723 shares worth $3.51M. The position accounts for 0.02% of the portfolio, ranked #547.

D.A. Davidson & Co first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • D.A. Davidson & Co held 40,723 shares of Zimmer Biomet worth $3.51M as of Q2 2026.
  • D.A. Davidson & Co bought 11,203 Zimmer Biomet shares in Q2 2026, an estimated $982K.
  • Zimmer Biomet made up 0.02% of D.A. Davidson & Co's portfolio in Q2 2026, its #547 holding.
  • D.A. Davidson & Co first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on D.A. Davidson & Co's 13F filing for Q2 2026, filed 24 Jul 2026.